{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:47:04Z","timestamp":1775105224625,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Council of Scientific and Industrial Research, New Delhi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04790-9","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:34:13Z","timestamp":1763368453000},"page":"5929-5946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CaMKII phosphorylation promotes renal fibrosis in cisplatin induced chronic kidney disease via Smad 2\/3 activation"],"prefix":"10.1007","volume":"399","author":[{"given":"Bhawna","family":"Tomar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divyansh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0600-0533","authenticated-orcid":false,"given":"Srikanta Kumar","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"2","key":"4790_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11096-013-9912-7","volume":"36","author":"Y Bennis","year":"2014","unstructured":"Bennis Y, Savry A, Rocca M, Gauthier-Villano L, Pisano P, Pourroy B (2014) Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow? Int J Clin Pharm 36(2):420\u2013429. https:\/\/doi.org\/10.1007\/s11096-013-9912-7","journal-title":"Int J Clin Pharm"},{"issue":"June","key":"4790_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.matbio.2023.05.002","volume":"120","author":"R Besio","year":"2023","unstructured":"Besio R, Contento BM, Garibaldi N, Filibian M, Sonntag S, Shmerling D, Tonelli F et al (2023) CaMKII Inhibition Due to TRIC-B Loss-of-Function Dysregulates SMAD Signaling in Osteogenesis Imperfecta. Matrix Biology\u202f: Journal of the International Society for Matrix Biology 120(June):43\u201359. https:\/\/doi.org\/10.1016\/j.matbio.2023.05.002","journal-title":"Matrix Biology : Journal of the International Society for Matrix Biology"},{"issue":"11","key":"4790_CR3","doi-asserted-by":"publisher","first-page":"F1414","DOI":"10.1152\/ajprenal.00426.2015","volume":"310","author":"C Bracken","year":"2016","unstructured":"Bracken C, Beauverger P, Duclos O, Russo RJ, Rogers KA, Husson H, Natoli TA et al (2016) CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of Nephronophthisis. Am J Physiol-Renal Physiol 310(11):F1414\u2013F1422. https:\/\/doi.org\/10.1152\/ajprenal.00426.2015","journal-title":"Am J Physiol-Renal Physiol"},{"key":"4790_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120845","volume":"306","author":"EG El-Waseif","year":"2022","unstructured":"El-Waseif EG, Sharawy MH, Suddek GM (2022) The modulatory effect of sodium molybdate against Cisplatin-induced CKD: role of TGF-\u03b2\/Smad signaling pathway. Life Sci 306:120845. https:\/\/doi.org\/10.1016\/j.lfs.2022.120845","journal-title":"Life Sci"},{"issue":"3","key":"4790_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/jpet.123.001621","volume":"386","author":"X Feng","year":"2023","unstructured":"Feng X, Zhang J, Yang R, Bai J, Deng B, Cheng Lu, Gao F, Xie J, Zhang B (2023) The CaMKII inhibitory peptide AIP alleviates renal fibrosis through the TGF-\u03b2\/Smad and RAF\/ERK pathways. J Pharmacol Exp Ther 386(3):310\u2013322. https:\/\/doi.org\/10.1124\/jpet.123.001621","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"4790_CR6","doi-asserted-by":"publisher","first-page":"F1582","DOI":"10.1152\/ajprenal.00385.2019","volume":"317","author":"Y Fu","year":"2019","unstructured":"Fu Y, Cai J, Li F, Liu Z, Shu S, Wang Y, Liu Y, Tang C, Dong Z (2019) Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells. Am J Physiol-Renal Physiol 317(6):F1582\u2013F1592. https:\/\/doi.org\/10.1152\/ajprenal.00385.2019","journal-title":"Am J Physiol-Renal Physiol"},{"key":"4790_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.918732","volume":"13","author":"Y Fu","year":"2022","unstructured":"Fu Y, Xiang Yu, Wenwen Wu, Cai J, Tang C, Dong Z (2022) Persistent Activation of Autophagy After Cisplatin Nephrotoxicity Promotes Renal Fibrosis and Chronic Kidney Disease. Front Pharmacol 13:918732. https:\/\/doi.org\/10.3389\/fphar.2022.918732","journal-title":"Front Pharmacol"},{"issue":"9","key":"4790_CR8","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.7150\/thno.81406","volume":"13","author":"Y Fu","year":"2023","unstructured":"Fu Y, Xiang Yu, Wang Y, Liu Z, Yang D, Zha J, Tang C, Cai J, Chen G, Dong Z (2023) The STAT1\/HMGB1\/NF-\u039aB pathway in chronic inflammation and kidney injury after cisplatin exposure. Theranostics 13(9):2757\u20132773. https:\/\/doi.org\/10.7150\/thno.81406","journal-title":"Theranostics"},{"issue":"January","key":"4790_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pharmtox-051421-111814","volume":"63","author":"OER Gaido","year":"2023","unstructured":"Gaido OER, Nkashama LJ, Schole KL, Wang Q, Umapathi P, Mesubi OO, Konstantinidis K, Luczak ED, Anderson ME (2023) CaMKII as a Therapeutic Target in Cardiovascular Disease. Annu Rev Pharmacol Toxicol 63:249\u2013272. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051421-111814","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"4790_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-021-03315-0","volume":"21","author":"J Gu","year":"2021","unstructured":"Gu J, Wang X, Zhang L, Xiang J, Li J, Chen Z, Zhang Yu, Chen J, Shen J (2021) Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKII\u03b3\/c-Myc\/CDK6 signaling pathway. BMC Complement Med Ther 21(1):163. https:\/\/doi.org\/10.1186\/s12906-021-03315-0","journal-title":"BMC Complement Med Ther"},{"issue":"6","key":"4790_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10157-023-02324-2","volume":"27","author":"A Hino","year":"2023","unstructured":"Hino A, Muto S, Shimada Y, Hori S, Isotani S, Nagata M, Horie S (2023) Impact of Cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors. Clin Exp Nephrol 27(6):506\u2013518. https:\/\/doi.org\/10.1007\/s10157-023-02324-2","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"4790_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2172961","volume":"45","author":"Z Huang","year":"2023","unstructured":"Huang Z, Peng Y, Ke G, Xiao Y, Chen Y (2023) CaMKII may regulate renal tubular epithelial cell apoptosis through YAP\/NFAT2 in acute kidney injury mice. Ren Fail 45(1):2172961. https:\/\/doi.org\/10.1080\/0886022X.2023.2172961","journal-title":"Ren Fail"},{"key":"4790_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev.biochem.71.110601.135410","volume":"71","author":"A Hudmon","year":"2002","unstructured":"Hudmon A, Schulman H (2002) Neuronal CA2+\/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473\u2013510. https:\/\/doi.org\/10.1146\/annurev.biochem.71.110601.135410","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"4790_CR14","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/db13-0816","volume":"63","author":"SS Jain","year":"2014","unstructured":"Jain SS, Paglialunga S, Vigna C, Ludzki A, Herbst EA, Lally JS, Schrauwen P et al (2014) High-fat diet-induced mitochondrial biogenesis is regulated by mitochondrial-derived reactive oxygen species activation of CaMKII. Diabetes 63(6):1907\u20131913. https:\/\/doi.org\/10.2337\/db13-0816","journal-title":"Diabetes"},{"issue":"51","key":"4790_CR15","doi-asserted-by":"publisher","first-page":"36598","DOI":"10.1074\/jbc.M113.488122","volume":"288","author":"AD Kistler","year":"2013","unstructured":"Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, Wilson C et al (2013) Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem 288(51):36598\u201336609. https:\/\/doi.org\/10.1074\/jbc.M113.488122","journal-title":"J Biol Chem"},{"issue":"20","key":"4790_CR16","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1111\/jcmm.17560","volume":"26","author":"L Kong","year":"2022","unstructured":"Kong L, Zhang Y, Ning J, Xu C, Wang Z, Yang J, Yang L (2022) CaMKII orchestrates endoplasmic reticulum stress and apoptosis in doxorubicin-induced cardiotoxicity by regulating the IRE1\u03b1\/XBP1s pathway. J Cell Mol Med 26(20):5303\u20135314. https:\/\/doi.org\/10.1111\/jcmm.17560","journal-title":"J Cell Mol Med"},{"issue":"7","key":"4790_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2215\/CJN.08070715","volume":"11","author":"S Latcha","year":"2016","unstructured":"Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD (2016) Long-term renal outcomes after cisplatin treatment. Clin J Am Soc Nephrol 11(7):1173\u20131179. https:\/\/doi.org\/10.2215\/CJN.08070715","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4790_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.07.001","volume":"383","author":"S Li","year":"2019","unstructured":"Li S, Lin Q, Shao X, Mou S, Gu L, Wang L, Zhang Z et al (2019) NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation. Exp Cell Res 383(1):111488. https:\/\/doi.org\/10.1016\/j.yexcr.2019.07.001","journal-title":"Exp Cell Res"},{"key":"4790_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166643","author":"S Li","year":"2023","unstructured":"Li S, Livingston MJ, Ma Z, Hu X, Wen Lu, Ding H-F, Zhou D, Dong Z (2023) Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.166643","journal-title":"JCI Insight"},{"issue":"4","key":"4790_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3892\/br.2021.1414","volume":"14","author":"T Liang","year":"2021","unstructured":"Liang T, Wei C, Sisi Lu, Qin M, Qin G, Zhang Y, Zhong X, Zou X, Yang Y (2021) Ginaton Injection Alleviates Cisplatin-Induced Renal Interstitial Fibrosis in Rats via Inhibition of Apoptosis through Regulation of the P38MAPK\/TGF-\u03921 and P38MAPK\/HIF-1\u03b1 Pathways. Biomedical Reports 14(4):38. https:\/\/doi.org\/10.3892\/br.2021.1414","journal-title":"Biomedical Reports"},{"issue":"1","key":"4790_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23238","volume":"37","author":"K Liu","year":"2023","unstructured":"Liu K, Hu C, Yin W, Zhou L, Gu X, Zuo X (2023) An in vivo and in vitro model on the protective effect of Cilnidipine on contrast-induced nephropathy via regulation of apoptosis and CaMK\u2161\/MPTP pathway. J Biochem Mol Toxicol 37(1):e23238. https:\/\/doi.org\/10.1002\/jbt.23238","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"4790_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/jnnp.65.6.836","volume":"65","author":"PO Lundberg","year":"1998","unstructured":"Lundberg PO (1998) Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 65(6):836\u2013841. https:\/\/doi.org\/10.1136\/jnnp.65.6.836","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4790_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166933","volume":"1870","author":"D Lv","year":"2024","unstructured":"Lv D, Lin Z, Liao X, Peng R, Liu H, Wu T, Wu K, Sun Y, Zhang Z (2024) Sfrp2 promotes renal dysfunction of diabetic kidney disease via modulating Fzd5-induced cytosolic calcium ion concentration and CaMKII\/Mek\/Erk pathway in mesangial cells. Biochim Biophys Acta Mol Basis Dis 1870(2):166933. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166933","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4790_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.redox.2018.09.020","volume":"20","author":"KA Mapuskar","year":"2019","unstructured":"Mapuskar KA, Wen H, Holanda DG, Rastogi P, Steinbach E, Han R, Coleman MC et al (2019) Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease. Redox Biol 20:98\u2013106. https:\/\/doi.org\/10.1016\/j.redox.2018.09.020","journal-title":"Redox Biol"},{"issue":"1","key":"4790_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41581-024-00889-z","volume":"21","author":"V Miguel","year":"2025","unstructured":"Miguel V, Shaw IW, Kramann R (2025) Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol 21(1):39\u201356. https:\/\/doi.org\/10.1038\/s41581-024-00889-z","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"4790_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11653","volume":"8","author":"AV Mikhailov","year":"2022","unstructured":"Mikhailov AV, Liu Y, Cheng H-J, Lin J-J, Cheng CP (2022) Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice. Heliyon 8(11):e11653. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11653","journal-title":"Heliyon"},{"key":"4790_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00035","volume":"11","author":"D Nassal","year":"2020","unstructured":"Nassal D, Gratz D, Hund TJ (2020) Challenges and opportunities for therapeutic targeting of calmodulin kinase II in heart. Front Pharmacol 11:35. https:\/\/doi.org\/10.3389\/fphar.2020.00035","journal-title":"Front Pharmacol"},{"key":"4790_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010408","author":"S Panizo","year":"2021","unstructured":"Panizo S, Mart\u00ednez-Arias L, Alonso-Montes C, Cannata P, Mart\u00edn-Carro B, Fern\u00e1ndez-Mart\u00edn JL, Naves-D\u00edaz M, Carrillo-L\u00f3pez N, Cannata-And\u00eda JB (2021) Fibrosis in chronic kidney disease: pathogenesis and consequences. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010408","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4790_CR29","doi-asserted-by":"publisher","first-page":"F329","DOI":"10.1152\/ajprenal.00358.2017","volume":"314","author":"E-J Park","year":"2018","unstructured":"Park E-J, Jung HJ, Choi H-J, Cho J-I, Park H-J, Kwon T-H (2018) MiR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells. Am J Physiol Renal Physiol 314(3):F329\u2013F342. https:\/\/doi.org\/10.1152\/ajprenal.00358.2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"4790_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00021","volume":"5","author":"P Pellicena","year":"2014","unstructured":"Pellicena P, Schulman H (2014) CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol 5:21. https:\/\/doi.org\/10.3389\/fphar.2014.00021","journal-title":"Front Pharmacol"},{"issue":"11","key":"4790_CR31","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s11255-022-03284-4","volume":"54","author":"Z Qing","year":"2022","unstructured":"Qing Z, Yuan W, Wang J, Song W, Luo J, Wu X, Lu Q, Li Y, Zeng M (2022) Verapamil inhibited the development of ureteral stricture by blocking CaMK II-mediated STAT3 and Smad3\/JunD pathways. Int Urol Nephrol 54(11):2855\u20132866. https:\/\/doi.org\/10.1007\/s11255-022-03284-4","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4790_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.joca.2018.08.017","volume":"27","author":"B Saitta","year":"2019","unstructured":"Saitta B, Elphingstone J, Limfat S, Shkhyan R, Evseenko D (2019) CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGF\u03b2 and BMP through SMAD signaling. Osteoarthritis Cartilage 27(1):158\u2013171. https:\/\/doi.org\/10.1016\/j.joca.2018.08.017","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"4790_CR33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41374-018-0063-2","volume":"98","author":"M Shi","year":"2018","unstructured":"Shi M, McMillan KL, Wu J, Gillings N, Flores B, Moe OW, Hu MC (2018) Cisplatin nephrotoxicity as a model of chronic kidney disease. Lab Invest 98(8):1105\u20131121. https:\/\/doi.org\/10.1038\/s41374-018-0063-2","journal-title":"Lab Invest"},{"issue":"8","key":"4790_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04480-2","volume":"79","author":"S Shu","year":"2022","unstructured":"Shu S, Wang H, Zhu J, Fu Y, Cai J, Chen A, Tang C, Dong Z (2022) Endoplasmic reticulum stress contributes to Cisplatin-induced chronic kidney disease via the PERK-PKC\u03b4 pathway. Cell Mol Life Sci 79(8):452. https:\/\/doi.org\/10.1007\/s00018-022-04480-2","journal-title":"Cell Mol Life Sci"},{"key":"4790_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051079","author":"KM Sim","year":"2020","unstructured":"Sim KM, Lee Y-S, Kim HJ, Cho C-H, Yi G-S,  Park M-J, Hwang EM, Park J-Y (2020) Suppression of CaMKII\u03b2 inhibits ANO1-mediated glioblastoma progression. Cells. https:\/\/doi.org\/10.3390\/cells9051079","journal-title":"Cells"},{"issue":"September","key":"4790_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.matbio.2022.08.005","volume":"112","author":"A Srivastava","year":"2022","unstructured":"Srivastava A, Tomar B, Sharma P, Kumari S, Prakash S, Rath SK, Kulkarni OP, Gupta SK, Mulay SR (2022) RIPK3-MLKL Signaling Activates Mitochondrial CaMKII and Drives Intrarenal Extracellular Matrix Production during CKD. Matrix Biology\u202f: Journal of the International Society for Matrix Biology 112(September):72\u201389. https:\/\/doi.org\/10.1016\/j.matbio.2022.08.005","journal-title":"Matrix Biology : Journal of the International Society for Matrix Biology"},{"issue":"1","key":"4790_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","volume":"19","author":"C Tang","year":"2023","unstructured":"Tang C, Livingston MJ, Safirstein R, Dong Z (2023) Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat Rev Nephrol 19(1):53\u201372. https:\/\/doi.org\/10.1038\/s41581-022-00631-7","journal-title":"Nat Rev Nephrol"},{"key":"4790_CR38","doi-asserted-by":"publisher","unstructured":"Wang Y-Y, Ren Z, Hong Z (2015) The Emerging Role of CaMKII in Cancer.\u00a0Oncotarget 6(14):11725\u201334. https:\/\/doi.org\/10.18632\/oncotarget.3955","DOI":"10.18632\/oncotarget.3955"},{"key":"4790_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174603","volume":"916","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu Q, Cai J, Wu P, Wang Di, Shi Y, Huyan T et al (2022) Emodin prevents renal ischemia-reperfusion injury via suppression of CAMKII\/DRP1-mediated mitochondrial fission. Eur J Pharmacol 916:174603. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174603","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4790_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-022-00574-y","volume":"17","author":"C Wei","year":"2022","unstructured":"Wei C, Zhang Y, Zhong X, Lu S, Zou X, Yang Y, Huang S, Huang Z (2022) Ginkgo biloba leaf extract mitigates cisplatin-induced chronic renal interstitial fibrosis by inhibiting the epithelial-mesenchymal transition of renal tubular epithelial cells mediated by the Smad3\/TGF-\u03921 and Smad3\/P38 MAPK pathways. Chin Med 17(1):25. https:\/\/doi.org\/10.1186\/s13020-022-00574-y","journal-title":"Chin Med"},{"issue":"1","key":"4790_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86496-9","volume":"15","author":"L Yang","year":"2025","unstructured":"Yang L, Si P, Kuerban T, Guo L, Zhan S, Zuhaer Y, Zuo Y, Lu P, Bai X, Liu T (2025) UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-\u03b2\/SMAD signaling pathway. Sci Rep 15(1):3346. https:\/\/doi.org\/10.1038\/s41598-025-86496-9","journal-title":"Sci Rep"},{"issue":"21","key":"4790_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70286","volume":"13","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang Z, Wang N, Yang J, Yang L (2024) CaMKII exacerbates doxorubicin-induced cardiotoxicity by promoting ubiquitination through USP10 inhibition. Cancer Med 13(21):e70286. https:\/\/doi.org\/10.1002\/cam4.70286","journal-title":"Cancer Med"},{"issue":"6","key":"4790_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/CIRCRESAHA.121.319478","volume":"130","author":"Y Yao","year":"2022","unstructured":"Yao Y, Li F, Zhang M, Jin Li, Xie P, Liu D, Zhang J et al (2022) Targeting CaMKII-\u03949 ameliorates cardiac ischemia\/reperfusion injury by inhibiting myocardial inflammation. Circ Res 130(6):887\u2013903. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319478","journal-title":"Circ Res"},{"issue":"1","key":"4790_CR44","doi-asserted-by":"publisher","DOI":"10.7603\/s40681-016-0005-5","volume":"6","author":"C-C Yu","year":"2016","unstructured":"Yu C-C, Chien C-T, Chang T-C (2016) M2 macrophage polarization modulates epithelial-mesenchymal transition in cisplatin-induced tubulointerstitial fibrosis. Biomedicine 6(1):5. https:\/\/doi.org\/10.7603\/s40681-016-0005-5","journal-title":"Biomedicine"},{"issue":"15","key":"4790_CR45","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1161\/CIRCULATIONAHA.121.055920","volume":"145","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liang R, Wang K, Zhang W, Zhang M, Jin Li, Xie P et al (2022) Novel CaMKII-\u03b4 inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia\/reperfusion injury and inhibit tumor growth. Circulation 145(15):1154\u20131168. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055920","journal-title":"Circulation"},{"issue":"1","key":"4790_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00964-y","volume":"30","author":"S Zhang","year":"2024","unstructured":"Zhang S, Feng X, Yang G, Tan H, Cheng X, Tang Q, Yang H et al (2024) Dexmedetomidine ameliorates acute kidney injury by regulating mitochondrial dynamics via the \u03912-AR\/SIRT1\/PGC-1\u03b1 pathway activation in rats. Mol Med 30(1):184. https:\/\/doi.org\/10.1186\/s10020-024-00964-y","journal-title":"Mol Med"},{"issue":"4","key":"4790_CR47","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1159\/000495681","volume":"51","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Feng J, Wang Qi, Zhao S, Yang S, Tian Lu, Meng P, Li J, Li H (2018) Hyperglycaemia stress-induced renal injury is caused by extensive mitochondrial fragmentation, attenuated MKP1 signalling, and activated JNK-CaMKII-Fis1 biological axis. Cell Physiol Biochem 51(4):1778\u20131798. https:\/\/doi.org\/10.1159\/000495681","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"4790_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02050-x","volume":"21","author":"J Zhou","year":"2020","unstructured":"Zhou J, Liu S, Guo L, Wang R, Chen J, Shen J (2020) NMDA receptor-mediated CaMKII\/ERK activation contributes to renal fibrosis. BMC Nephrol 21(1):392. https:\/\/doi.org\/10.1186\/s12882-020-02050-x","journal-title":"BMC Nephrol"},{"issue":"3","key":"4790_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000926RR","volume":"35","author":"R Zhou","year":"2021","unstructured":"Zhou R, Liao J, Cai D, Tian Q, Huang E, L\u00fc T, Chen S-Y, Xie W-B (2021) Nupr1 mediates renal fibros","journal-title":"FASEB J"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04790-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:21:12Z","timestamp":1775100072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04790-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4790"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04790-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}